B. Riley Wealth Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

B. Riley Wealth Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,978	Closed	-$552K	–	1509
2021 Q1	$552K	Buy	5,978 +1,128	+23%	+$95.2K	0.02%	687
2020 Q4	$356K	Sell	4,850 -3,396	-41%	-$252K	0.02%	667
2020 Q3	$637K	Buy	8,246 +4,343	+111%	+$299K	0.03%	449
2020 Q2	$218K	Buy	+3,903	New	+$167K	0.01%	747
2020 Q1	–	Sell	-7,053	Closed	-$256K	–	930
2019 Q4	$256K	Buy	+7,053	New	+$216K	0.02%	670
2015 Q3	–	Sell	-8,336	Closed	-$290K	–	616
2015 Q2	$290K	Buy	+8,336	New	+$254K	0.07%	341
2014 Q3	–	Sell	-2,475	Closed	-$39.2K	–	2170
2014 Q2	$39.2K	Buy	+2,475	New	+$35.3K	0.01%	1136
2013 Q4	–	Sell	-34,813	Closed	-$117K	–	732
2013 Q3	$117K	Buy	+34,813	New	+$91.8K	0.04%	503

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

B. Riley Wealth Advisors's HZNP Position: Q2 2021 in Review

B. Riley Wealth Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 5,978 shares — an estimated $552K sold.

B. Riley Wealth Advisors first reported a position in HZNP in Q3 2013 and held it in 8 quarters. The position peaked at $637K in Q3 2020. 527 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

B. Riley Wealth Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
B. Riley Wealth Advisors sold 5,978 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $552K.
B. Riley Wealth Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 8 quarters.
B. Riley Wealth Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $637K in Q3 2020.
527 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.